Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial

<table>Design of the trial to compare oral vitamin D (0.5 <i>μ</i>g/day) versus placebo in patients with relapsing-remitting multiple sclerosis.</table>

Multiple Sclerosis International

fig1

Figure 1

Figure 1: Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial 

Figure 1 | Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial 